New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Omar Khoja,  Matthew Mulvey, Sarah Astill,  et. al. ,doi: https://doi.org/10.1101/2024.07.10.24310234 ABSTRACT Background New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the…[...]

Read More

Ideological diversity of media consumption predicts COVID-19 vaccination

Marrissa D. Grant, David M. Markowitz, David K. Sherman, et. al., Scientific Reports volume 14, Article number: 28948 (2024)  Abstract This study examines the relationship between respondents’ vaccine hesitancy, reported media consumption patterns, ideological leanings, and…[...]

Read More

Evidence on Long COVID Diagnosis, Risk, Symptoms, and Functional Impact for Patients

News Release |  2024, National Academies of Sciences, Engineering, and Medicine WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine presents conclusions about Long COVID diagnosis, symptoms, and…[...]

Read More

Study Censored by The Lancet Finally Released: Confirms ‘High Likelihood of Causal Link Between COVID-19 Vaccines and Death’

On November 17, 2024, Science, Public Health Policy and The Law journal published a peer-reviewed study titled, “A Systematic Review Of Autopsy Findings In Deaths After Covid-19 Vaccination.“ This study…[...]

Read More

NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Part of the NIH RECOVER Initiative, trials will test four treatments. The National Institutes of Health (NIH) will launch clinical trials to investigate potential treatments for long-term symptoms after COVID-19…[...]

Read More

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Authors: Bruce K. Patterson, 1 , * Edgar B. Francisco, 1 Ram Yogendra, 2 et. al., Front Immunol. 2021; 12: 746021.Published online 2022 Jan 10. doi: 10.3389/fimmu.2021. 746021PMCID: PMC8784688PMID: 35082777 Abstract The recent COVID-19 pandemic is a treatment challenge in the acute…[...]

Read More